Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1993 2
1994 1
1995 1
1996 1
1997 1
1998 1
1999 2
2000 3
2001 3
2002 2
2003 3
2004 4
2005 4
2006 7
2007 6
2008 3
2009 6
2010 4
2011 7
2012 8
2013 5
2014 11
2015 12
2016 10
2017 12
2018 8
2019 17
2020 12
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

143 results
Results by year
Filters applied: . Clear all
Page 1
Oncolytic Virotherapy for the Treatment of Malignant Glioma.
Foreman PM, Friedman GK, Cassady KA, Markert JM. Foreman PM, et al. Among authors: markert jm. Neurotherapeutics. 2017 Apr;14(2):333-344. doi: 10.1007/s13311-017-0516-0. Neurotherapeutics. 2017. PMID: 28265902 Free PMC article. Review.
Oncolytic herpes simplex virus immunotherapy for brain tumors: current pitfalls and emerging strategies to overcome therapeutic resistance.
Totsch SK, Schlappi C, Kang KD, Ishizuka AS, Lynn GM, Fox B, Beierle EA, Whitley RJ, Markert JM, Gillespie GY, Bernstock JD, Friedman GK. Totsch SK, et al. Among authors: markert jm. Oncogene. 2019 Aug;38(34):6159-6171. doi: 10.1038/s41388-019-0870-y. Epub 2019 Jul 9. Oncogene. 2019. PMID: 31289361 Free PMC article. Review.
Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation.
Minata M, Audia A, Shi J, Lu S, Bernstock J, Pavlyukov MS, Das A, Kim SH, Shin YJ, Lee Y, Koo H, Snigdha K, Waghmare I, Guo X, Mohyeldin A, Gallego-Perez D, Wang J, Chen D, Cheng P, Mukheef F, Contreras M, Reyes JF, Vaillant B, Sulman EP, Cheng SY, Markert JM, Tannous BA, Lu X, Kango-Singh M, Lee LJ, Nam DH, Nakano I, Bhat KP. Minata M, et al. Among authors: markert jm. Cell Rep. 2019 Feb 12;26(7):1893-1905.e7. doi: 10.1016/j.celrep.2019.01.076. Cell Rep. 2019. PMID: 30759398 Free PMC article.
Efficacy of osimertinib against EGFRvIII+ glioblastoma.
Chagoya G, Kwatra SG, Nanni CW, Roberts CM, Phillips SM, Nullmeyergh S, Gilmore SP, Spasojevic I, Corcoran DL, Young CC, Ballman KV, Ramakrishna R, Cross DA, Markert JM, Lim M, Gilbert MR, Lesser GJ, Kwatra MM. Chagoya G, et al. Among authors: markert jm. Oncotarget. 2020 Jun 2;11(22):2074-2082. doi: 10.18632/oncotarget.27599. eCollection 2020 Jun 2. Oncotarget. 2020. PMID: 32547705 Free PMC article.
A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma.
Wen PY, Reardon DA, Armstrong TS, Phuphanich S, Aiken RD, Landolfi JC, Curry WT, Zhu JJ, Glantz M, Peereboom DM, Markert JM, LaRocca R, O'Rourke DM, Fink K, Kim L, Gruber M, Lesser GJ, Pan E, Kesari S, Muzikansky A, Pinilla C, Santos RG, Yu JS. Wen PY, et al. Among authors: markert jm. Clin Cancer Res. 2019 Oct 1;25(19):5799-5807. doi: 10.1158/1078-0432.CCR-19-0261. Epub 2019 Jul 18. Clin Cancer Res. 2019. PMID: 31320597 Free article. Clinical Trial.
Brain metastases.
Shaffrey ME, Mut M, Asher AL, Burri SH, Chahlavi A, Chang SM, Farace E, Fiveash JB, Lang FF, Lopes MB, Markert JM, Schiff D, Siomin V, Tatter SB, Vogelbaum MA. Shaffrey ME, et al. Among authors: markert jm. Curr Probl Surg. 2004 Aug;41(8):665-741. doi: 10.1067/j.cpsurg.2004.06.001. Curr Probl Surg. 2004. PMID: 15354117 Review. No abstract available.
Anti-SSTR2 antibody-drug conjugate for neuroendocrine tumor therapy.
Si Y, Kim S, Ou J, Lu Y, Ernst P, Chen K, Whitt J, Carter AM, Markert JM, Bibb JA, Chen H, Zhou L, Jaskula-Sztul R, Liu XM. Si Y, et al. Among authors: markert jm. Cancer Gene Ther. 2020 Jul 20:10.1038/s41417-020-0196-5. doi: 10.1038/s41417-020-0196-5. Online ahead of print. Cancer Gene Ther. 2020. PMID: 32684623
143 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page